vs
Side-by-side financial comparison of COMERICA INC (CMA) and Incyte (INCY). Click either name above to swap in a different company.
Incyte is the larger business by last-quarter revenue ($1.3B vs $838.0M, roughly 1.5× COMERICA INC). Incyte runs the higher net margin — 23.8% vs 21.0%, a 2.8% gap on every dollar of revenue. On growth, Incyte posted the faster year-over-year revenue change (20.9% vs 3.3%). Over the past eight quarters, COMERICA INC's revenue compounded faster (108.9% CAGR vs 10.4%).
Comerica Incorporated is an American financial services company, headquartered in Dallas, Texas. It is the parent of Comerica Bank, a regional commercial bank with 413 branches in the U.S. states of Texas, Michigan, California, Florida and Arizona. Comerica is among the largest U.S. financial holding companies, with offices in a number of U.S. cities.
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
CMA vs INCY — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $838.0M | $1.3B |
| Net Profit | $176.0M | $303.3M |
| Gross Margin | — | — |
| Operating Margin | — | 23.7% |
| Net Margin | 21.0% | 23.8% |
| Revenue YoY | 3.3% | 20.9% |
| Net Profit YoY | -4.3% | 91.7% |
| EPS (diluted) | $1.35 | $1.47 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.3B | ||
| Q4 25 | — | $1.5B | ||
| Q3 25 | $838.0M | $1.4B | ||
| Q2 25 | $849.0M | $1.2B | ||
| Q1 25 | $829.0M | $1.1B | ||
| Q4 24 | $825.0M | $1.2B | ||
| Q3 24 | $811.0M | $1.1B | ||
| Q2 24 | $824.0M | $1.0B |
| Q1 26 | — | $303.3M | ||
| Q4 25 | — | $299.3M | ||
| Q3 25 | $176.0M | $424.2M | ||
| Q2 25 | $199.0M | $405.0M | ||
| Q1 25 | $172.0M | $158.2M | ||
| Q4 24 | $170.0M | $201.2M | ||
| Q3 24 | $184.0M | $106.5M | ||
| Q2 24 | $206.0M | $-444.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | 92.0% | ||
| Q3 25 | — | 92.8% | ||
| Q2 25 | — | 93.5% | ||
| Q1 25 | — | 93.0% | ||
| Q4 24 | — | 92.5% | ||
| Q3 24 | — | 92.4% | ||
| Q2 24 | — | 92.7% |
| Q1 26 | — | 23.7% | ||
| Q4 25 | — | 22.3% | ||
| Q3 25 | — | 32.5% | ||
| Q2 25 | — | 43.6% | ||
| Q1 25 | — | 19.5% | ||
| Q4 24 | — | 25.6% | ||
| Q3 24 | — | 12.8% | ||
| Q2 24 | — | -45.8% |
| Q1 26 | — | 23.8% | ||
| Q4 25 | — | 19.9% | ||
| Q3 25 | 21.0% | 31.1% | ||
| Q2 25 | 23.4% | 33.3% | ||
| Q1 25 | 20.7% | 15.0% | ||
| Q4 24 | 20.6% | 17.1% | ||
| Q3 24 | 22.7% | 9.4% | ||
| Q2 24 | 25.0% | -42.6% |
| Q1 26 | — | $1.47 | ||
| Q4 25 | — | $1.46 | ||
| Q3 25 | $1.35 | $2.11 | ||
| Q2 25 | $1.42 | $2.04 | ||
| Q1 25 | $1.25 | $0.80 | ||
| Q4 24 | $1.22 | $0.90 | ||
| Q3 24 | $1.33 | $0.54 | ||
| Q2 24 | $1.49 | $-2.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | $5.4B | — |
| Stockholders' EquityBook value | $7.4B | $5.6B |
| Total Assets | $77.4B | $7.3B |
| Debt / EquityLower = less leverage | 0.73× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $3.1B | ||
| Q3 25 | — | $2.5B | ||
| Q2 25 | — | $2.0B | ||
| Q1 25 | — | $1.9B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $987.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $5.4B | — | ||
| Q2 25 | $5.8B | — | ||
| Q1 25 | $5.7B | — | ||
| Q4 24 | $6.7B | — | ||
| Q3 24 | $6.8B | — | ||
| Q2 24 | $7.1B | — |
| Q1 26 | — | $5.6B | ||
| Q4 25 | — | $5.2B | ||
| Q3 25 | $7.4B | $4.7B | ||
| Q2 25 | $6.9B | $4.2B | ||
| Q1 25 | $7.1B | $3.7B | ||
| Q4 24 | $6.5B | $3.4B | ||
| Q3 24 | $7.4B | $3.2B | ||
| Q2 24 | $6.2B | $3.0B |
| Q1 26 | — | $7.3B | ||
| Q4 25 | — | $7.0B | ||
| Q3 25 | $77.4B | $6.3B | ||
| Q2 25 | $78.0B | $5.8B | ||
| Q1 25 | $77.6B | $5.7B | ||
| Q4 24 | $79.3B | $5.4B | ||
| Q3 24 | $79.7B | $5.0B | ||
| Q2 24 | $79.6B | $4.7B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.73× | — | ||
| Q2 25 | 0.84× | — | ||
| Q1 25 | 0.81× | — | ||
| Q4 24 | 1.02× | — | ||
| Q3 24 | 0.92× | — | ||
| Q2 24 | 1.15× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-270.0M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | -1.53× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $543.3M | ||
| Q3 25 | $-270.0M | $559.4M | ||
| Q2 25 | $476.0M | $44.7M | ||
| Q1 25 | $273.0M | $266.1M | ||
| Q4 24 | $601.0M | $381.2M | ||
| Q3 24 | $1.0B | $310.9M | ||
| Q2 24 | $111.0M | $-575.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.82× | ||
| Q3 25 | -1.53× | 1.32× | ||
| Q2 25 | 2.39× | 0.11× | ||
| Q1 25 | 1.59× | 1.68× | ||
| Q4 24 | 3.54× | 1.89× | ||
| Q3 24 | 5.70× | 2.92× | ||
| Q2 24 | 0.54× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
